Automation of a multiplex agglutination-PCR (ADAP) type 1 diabetes (T1D) assay for the rapid analysis of islet autoantibodies.

[1]  K. Herold,et al.  Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals , 2021, Science Translational Medicine.

[2]  A. Steck,et al.  Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes. , 2020, The New England journal of medicine.

[3]  Darrell M. Wilson,et al.  Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR , 2020, PloS one.

[4]  M. Pandori,et al.  Sensitive and Specific Detection of SARS-CoV-2 Antibodies Using a High-Throughput, Fully Automated Liquid-Handling Robotic System , 2020, SLAS Technology.

[5]  B. Akolkar,et al.  Islet Autoantibody Standardization Program 2018 Workshop: Interlaboratory Comparison of Glutamic Acid Decarboxylase Autoantibody Assay Performance. , 2019, Clinical chemistry.

[6]  M. Rewers,et al.  High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneously , 2019, EBioMedicine.

[7]  J. Krischer,et al.  An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. , 2019, The New England journal of medicine.

[8]  C. Bertozzi,et al.  Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis , 2018, Proceedings of the National Academy of Sciences.

[9]  C. Bertozzi,et al.  Isotype-specific agglutination-PCR (ISAP): A sensitive and multiplex method for measuring allergen-specific IgE. , 2017, The Journal of allergy and clinical immunology.

[10]  E. Bonifacio,et al.  Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study , 2016, BMJ Open.

[11]  M. Rewers,et al.  A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease. , 2016, Journal of immunological methods.

[12]  Carolyn R. Bertozzi,et al.  Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP) , 2016, ACS central science.

[13]  Å. Lernmark,et al.  Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association , 2015, Diabetes Care.

[14]  Bo Zhang,et al.  A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes , 2014, Nature Medicine.

[15]  M. Atkinson,et al.  Type 1 diabetes , 2014, The Lancet.

[16]  M. Rewers,et al.  GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes , 2013, Diabetes.

[17]  E. Bonifacio,et al.  Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. , 2013, JAMA.

[18]  A. Steck,et al.  Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity , 2013, Diabetes Care.

[19]  M. Rewers,et al.  Distinguishing Persistent Insulin Autoantibodies With Differential Risk , 2011, Diabetes.